Embecta Corp.

26.08+0.7600+3.00%Vol 567.31K1Y Perf -
Jul 1st, 2022 16:00 DELAYED
BID25.00 ASK27.92
Open25.15 Previous Close25.32
Pre-Market- After-Market26.08
 - -  - -%
Target Price
25.00 
Analyst Rating
Moderate Sell 4.00
Potential %
-4.14 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     55.88
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
8.90 
Earnings Rating
Market Cap1.51B 
Earnings Date
-
Alpha-0.19 Standard Deviation0.07
Beta-1.12 

Today's Price Range

24.1626.20

52W Range

23.8449.00

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Week
-2.94%
1 Month
-7.91%
3 Months
-14.49%
6 Months
-
1 Year
-
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
EMBC26.080.76003.00
AAPL138.932.21001.62
GOOG2 181.62-5.8300-0.27
MSFT259.582.75001.07
XOM87.551.91002.23
WFC39.920.75001.91
JNJ179.522.01001.13
FB196.640.99000.51
GE63.54-0.1300-0.20
JPM114.051.44001.28
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume567.31K
Shares Outstanding57.80K
Shares Float57.45M
Trades Count8.88K
Dollar Volume14.39M
Avg. Volume1.46M
Avg. Weekly Volume1.80M
Avg. Monthly Volume945.35K
Avg. Quarterly Volume1.63M

Embecta Corp. (NASDAQ: EMBC) stock closed at 26.08 per share at the end of the most recent trading day (a 3% change compared to the prior day closing price) with a volume of 567.31K shares and market capitalization of 1.51B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 2029 people. Embecta Corp. CEO is .

The one-year performance of Embecta Corp. stock is %, while year-to-date (YTD) performance is %. EMBC stock has a five-year performance of %. Its 52-week range is between 23.84 and 49, which gives EMBC stock a 52-week price range ratio of 8.90%

Embecta Corp. currently has a PE ratio of 4.10, a price-to-book (PB) ratio of 2.61, a price-to-sale (PS) ratio of 1.35, a price to cashflow ratio of 2.90, a PEG ratio of 2.32, a ROA of 45.61%, a ROC of 74.21% and a ROE of -39.30%. The company’s profit margin is 32.80%, its EBITDA margin is 42.00%, and its revenue ttm is $1.16 Billion , which makes it $20.06 revenue per share.

Of the last four earnings reports from Embecta Corp., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Embecta Corp.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Embecta Corp. is Moderate Sell (4), with a target price of $25, which is -4.14% compared to the current price. The earnings rating for Embecta Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Embecta Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Embecta Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 9.07, ATR14 : 1.69, CCI20 : -166.86, Chaikin Money Flow : -0.43, MACD : -0.55, Money Flow Index : 26.02, ROC : -5.20, RSI : 43.71, STOCH (14,3) : 33.10, STOCH RSI : 0.63, UO : 43.31, Williams %R : -66.90), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Embecta Corp. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0
0
Moderate Buy
0 (0.00 %)
0
0
Hold
0 (0.00 %)
0
0
Moderate Sell
1 (100.00 %)
0
0
Strong Sell
0 (0.00 %)
0
0
Summary RatingModerate Sell
4.00
-
0.00
-
0.00

Embecta Corp.

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

CEO:

Telephone: +1 201 847-6880

Address: 1 Becton Drive, Franklin Lakes 07417-1880, NJ, US

Number of employees: 2 029

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits